Data library

This data library has been put together to facilitate your consultation of the data, figures and sources that have been used in the compilation of the 2006 selected issues.

Selected issue 1: European drug policies: extended beyond illicit drugs?

Figures
This selected issue has no associated figures.

Tables

Table 1: Substances or behaviours targeted in national drug strategies

Table 2: Strategies existing in the countries

Text boxes
This selected issue has no associated text boxes.

Selected issue 2: A gender perspective on drug use and responding to drug problems

Figures

Figure 1: Male to female ratios for ever in lifetime use of cannabis among 15- to 16-year-old students and all adults (15–64 years)

Figure 2: Male to female ratios for ever in lifetime, last year and last month cannabis use among all adults (15–64 years)

Figure 3: Male to female ratios for ever in lifetime or repeated (40+ in lifetime) cannabis use among 15- to 16-year-old school students

Figure 4: Male to female ratios for ever in lifetime use of cannabis among 15- to 16-year-old school students in the 1995 or 2003 rounds of the ESPAD survey

Figure 5: Male to female ratios for ever in lifetime use of ecstasy among 15- 16-year-old school students and all adults (15–64 years)

Figure 6: Prevalence of ever in lifetime use of cocaine among 15–34 year olds in the general population, by gender

Figure 7: Male to female ratios among 15–16 year old school students reporting ever in lifetime use of tranquillisers or sedatives without a doctor's prescription

Figure 8: Male to female ratios for consumption of five or more drinks in one session during the last 30 days among 15- to 16-year-old students

Figure 9: Gender and the use of psychoactive substances by different user groups – ever in lifetime prevalence of use of nine psychoactive substances among 15- to 16-year-old students in 15 European countries

Tables

Table 1: Male to female ratio among observed drug users and in estimates of the hidden population (capture–recapture method)

Text boxes

Methodology

Quartier Intermédiaire Sortantes



Selected issue 3: Developments in drug use within recreational settings

Figures

Figure 1: Comparison of last month use of cannabis, cocaine and ecstasy among the electronic music club population in France and general population of young adults (15–24 years) (odds ratio)

Figure 2: Prevalence of ever in lifetime use of ecstasy in surveys carried out in club settings and among the general population

Figure 3: Prevalence of ever in lifetime use of amphetamines in surveys carried out in club settings and among the general population

Figure 4: Prevalence of ever in lifetime use of cocaine in surveys carried out in club settings and among the general population

Figure 5: Prevalence of ever in lifetime use of LSD in surveys carried out in club settings and among the general population

Figure 6: Prevalence of ever in lifetime use of hallucinogenic mushrooms in surveys carried out in club settings and among the general population

Figure 7: Prevalence of ever in lifetime use and last month use of ecstasy, amphetamines and cocaine in dance music populations

Figure 8: Number of non-fatal emergencies due to drug use recorded by the Amsterdam municipal health service from 2000 to 20004

Figure 9: Number of patients admitted to on-site clinics with drug-related problems at the 'I Love Techno' event in Ghent, Belgium, November, 2001 (37 000 attendees)

Tables

Table 1: Drug studies and surveys conducted in dance music settings in Europe that provide the data and information reported in this selected issue

Table 2: Lifetime prevalence of use of GHB and ketamine in dance music surveys

Text boxes

Methodology

An example from Denmark – Roskilde festival/Festivaldanmark against drugs

Safer dancing guidelines